Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2009

View Archived Issues

Effects of donepezil treatment in AD; data from several studies disclosed at ICAD

Data from several studies on galantamine reported at ICAD

Tocotrienol shows potential therapeutic use in diabetic encephalopathy; preclinical data suggest

Novel S1P1 receptor agonists identified by GlaxoSmithKline

Nerviano Medical Sciences discovers novel cdc7 and AKT kinase inhibitors

NeuroSearch patent describes KCNQ channel activators

Novel ACC inhibitors emerge from AstraZeneca R&D

QuoNova presents bacterial biofilm formation inhibitors for the treatment of bacterial infections

Insmed ceases supply of Iplex to new patients and will not initiate further clinical trials

Novartis signs agreement with Avila for Avilomics covalent drug design platform

Yakult to initiate trial sites in Japan as part of Celsion's phase III trial of ThermoDox

CHMP recommends expanded use of MSD's Isentress in adult HIV patients

CHMP recommends Roche's MabThera in patients with relapsed or refractory CLL

Eisai submits MAA to Swissmedic for eribulin mesylate for breast cancer

Movetis receives positive opinion from CHMP for prucalopride in constipation

Tranzyme receives FDA Fast Track status for TZP-102

PTC initiates phase II PTC-299 trial in patients with neurofibromatosis type 2

Novel glucagon and GLP-1 co-agonist reduces obesity pathophysiology in rodents

ORL1 antagonist MK-1925 shows favorable preclinical activity, selected as clinical candidate

FDA issues complete response letter for Intuniv extended release for ADHD

Ariad reports preliminary results from ongoing AP-24534 trial in CML

Osiris achieves milestone payment for progress in phase II trial of Prochymal

Raptor and TorreyPines enter into definitive merger agreement

Quark reports results from study of QPI-1007 in a rat model of glaucoma

Bristol-Myers commences tender offer to acquire Medarex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...